Home LiteratureArticle Details
PMID: 15731243 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.

Journal of virology ·Vol. 79 ·No. 6 ·2005-03-00 ·Pages 3488-99

Delos SE, Godby JA, White JM

Abstract

The avian sarcoma/leukosis virus (ASLV) is activated for fusion by a two-step mechanism. For ASLV subgroup A (ASLV-A), association with its receptor (Tva) at neutral pH converts virions to a form that can bind target membranes and, in some assays, induce the lipid-mixing stage of fusion. Low pH is necessary to complete the fusion reaction. ASLV-A env (EnvA) exists on the viral surface as a trimer of heterodimers consisting of receptor binding (SU-A) and fusion-mediating (TM-A) subunits. As the receptor binding and fusion-mediating functions reside in separate subunits, we hypothesize that SU-A and TM-A are conformationally coupled. To begin to understand the effect of the binding of a soluble 47-residue domain of the receptor (sTva) on this coupling and the subsequent function of low pH, we prepared recombinant proteins representing full-length SU-A and a nested set of deletion mutant proteins. Full-length SU-A binds sTva with high affinity, but even small deletions at either the N or the C terminus severely impair sTva binding. We have purified the full-length SU-A subunit and characterized its interactions with sTva and the subsequent effect of low pH on the complex. sTva binds SU-A with an apparent KD of 3 pM. Complex formation occludes hydrophobic surfaces and tryptophan residues and leads to a partial loss of alpha-helical structure in SU-A. Low pH does not alter the off rate for the complex, further alter the secondary structure of SU-A, or induce measurable changes in tryptophan environment. The implications of these findings for fusion are discussed.

MeSH Terms
Avian Leukosis Virus/chemistry,physiology Avian Proteins Avian Sarcoma Viruses/chemistry,physiology Circular Dichroism Hydrogen-Ion Concentration Membrane Fusion Protein Binding Protein Conformation Protein Structure, Tertiary Protein Subunits/chemistry Receptors, Virus/metabolism Recombinant Proteins/chemistry,genetics,metabolism Sequence Deletion Solubility Spectrometry, Fluorescence Surface Plasmon Resonance Viral Envelope Proteins/chemistry,genetics,metabolism
Chemicals
Avian Proteins Protein Subunits Receptors, Virus Recombinant Proteins Tva receptor Viral Envelope Proteins glycoprotein 85, avian leukosis virus
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Delos Sue E
Department of Cell Biology, UVA Health System, School of Medicine, P.O. Box 800732, Charlottesville, VA 22908-0732, USA. sed7a@virginia.edu
Godby Jesse A
White Judith M
References (70)
70 references, click to expand
  1. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors.
    J Biol Chem. 1998 Jan 2;273(1):404-9 PMID: 9417096
  2. Receptor-triggered membrane association of a model retroviral glycoprotein.
    Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2580-5 PMID: 9482929
  3. Functional expression of the chicken low density lipoprotein receptor-related protein in a mutant chinese hamster ovary cell line restores toxicity of Pseudomonas exotoxin A and degradation of alpha2-macroglobulin.
    J Biol Chem. 1998 Mar 13;273(11):6057-65 PMID: 9497322
  4. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.
    Nature. 1998 Jun 18;393(6686):648-59 PMID: 9641677
  5. Production and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptor.
    J Virol. 1999 Apr;73(4):3054-61 PMID: 10074155
  6. Conformational intermediates and fusion activity of influenza virus hemagglutinin.
    J Virol. 1999 Jun;73(6):4567-74 PMID: 10233915
  7. Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein micro 1 mediates membrane disruption.
    J Virol. 2002 Oct;76(19):9920-33 PMID: 12208969
  8. Tight binding of influenza virus hemagglutinin to its receptor interferes with fusion pore dilation.
    J Virol. 2002 Dec;76(24):12405-13 PMID: 12438566
  9. Concordant modulation of neutralization resistance and high infectivity of the primary human immunodeficiency virus type 1 MN strain and definition of a potential gp41 binding site in gp120.
    J Virol. 2003 Jan;77(1):560-70 PMID: 12477860
  10. Structure of the LDL receptor extracellular domain at endosomal pH.
    Science. 2002 Dec 20;298(5602):2353-8 PMID: 12459547
  11. The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.
    J Virol. 2003 Mar;77(5):3058-66 PMID: 12584331
  12. Kinetic analysis of binding interaction between the subgroup A Rous sarcoma virus glycoprotein SU and its cognate receptor Tva: calcium is not required for ligand binding.
    J Virol. 2003 Jul;77(13):7517-26 PMID: 12805452
  13. Early steps of the conformational change of influenza virus hemagglutinin to a fusion active state: stability and energetics of the hemagglutinin.
    Biochim Biophys Acta. 2003 Jul 11;1614(1):3-13 PMID: 12873761
  14. The HIV Env-mediated fusion reaction.
    Biochim Biophys Acta. 2003 Jul 11;1614(1):36-50 PMID: 12873764
  15. Evolutionary pressure of a receptor competitor selects different subgroup a avian leukosis virus escape variants with altered receptor interactions.
    J Virol. 2003 Oct;77(19):10504-14 PMID: 12970435
  16. Functional evolution of the HIV-1 envelope glycoprotein 120 association site of glycoprotein 41.
    J Biol Chem. 2003 Oct 24;278(43):42149-60 PMID: 12923196
  17. Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites.
    Protein Expr Purif. 2004 Apr;34(2):284-95 PMID: 15003263
  18. Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth.
    J Virol. 2004 Apr;78(7):3753-62 PMID: 15016895
  19. The role of a conserved acidic residue in calcium-dependent protein folding for a low density lipoprotein (LDL)-A module: implications in structure and function for the LDL receptor superfamily.
    J Biol Chem. 2004 Apr 16;279(16):16629-37 PMID: 14749324
  20. X-ray structure of a minor group human rhinovirus bound to a fragment of its cellular receptor protein.
    Nat Struct Mol Biol. 2004 May;11(5):429-34 PMID: 15064754
  21. Effects of lipid rafts on dynamics of retroviral entry and trafficking: Quantitative analysis.
    Biotechnol Bioeng. 2004 Jun 20;86(6):650-60 PMID: 15137076
  22. Apolipoprotein E-low density lipoprotein receptor binding: study of protein-protein interaction in rationally selected docked complexes.
    Proteins. 2004 Jun 1;55(4):874-84 PMID: 15146486
  23. Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein.
    J Virol. 2004 Aug;78(15):8201-9 PMID: 15254191
  24. Identification of glycosylation sites in the SU component of the Avian Sarcoma/Leukosis virus Envelope Glycoprotein (Subgroup A) by mass spectrometry.
    Virology. 2004 Aug 15;326(1):171-81 PMID: 15262505
  25. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.
    Nature. 1981 Jan 29;289(5796):366-73 PMID: 7464906
  26. The avian retrovirus env gene family: molecular analysis of host range and antigenic variants.
    J Virol. 1988 Jan;62(1):75-83 PMID: 2824857
  27. Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion.
    J Gen Virol. 1988 Nov;69 ( Pt 11):2785-95 PMID: 3183628
  28. Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies.
    J Virol. 1988 Dec;62(12):4703-11 PMID: 2460639
  29. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.
    J Biol Chem. 1990 Jun 25;265(18):10373-82 PMID: 2355006
  30. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
    Science. 1990 Nov 23;250(4984):1139-42 PMID: 2251501
  31. The N-terminal 31 amino acids of human immunodeficiency virus type 1 envelope protein gp120 contain a potential gp41 contact site.
    J Virol. 1991 May;65(5):2682-5 PMID: 2016774
  32. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
    J Exp Med. 1991 Aug 1;174(2):407-15 PMID: 1713252
  33. Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity.
    Cell. 1992 Feb 21;68(4):635-45 PMID: 1739972
  34. Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin.
    J Virol. 1992 Aug;66(8):4940-50 PMID: 1629960
  35. Inhibition of viral capsid assembly by 1,1'-bi(4-anilinonaphthalene-5-sulfonic acid).
    Biochemistry. 1993 Oct 12;32(40):10658-65 PMID: 8399211
  36. Folding of the phage P22 coat protein in vitro.
    Biochemistry. 1993 Oct 12;32(40):10839-47 PMID: 8399234
  37. pH-dependent binding of the fluorophore bis-ANS to influenza virus reflects the conformational change of hemagglutinin.
    Eur Biophys J. 1994;23(2):105-13 PMID: 8050396
  38. The kinetics of the acid-induced conformational change of influenza virus haemagglutinin can be followed using 1,1'-bis(4-anilino-5-naphthalenesulphonic acid).
    Biochem Biophys Res Commun. 1995 Jan 5;206(1):355-61 PMID: 7818541
  39. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
    Nature. 1995 Jul 6;376(6535):92-4 PMID: 7596443
  40. Avian homologs of the mammalian low-density lipoprotein receptor family bind minor receptor group human rhinovirus.
    J Virol. 1995 Nov;69(11):7244-7 PMID: 7474146
  41. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein.
    J Virol. 1995 Dec;69(12):7410-5 PMID: 7494245
  42. Retrovirus envelope domain at 1.7 angstrom resolution.
    Nat Struct Biol. 1996 May;3(5):465-9 PMID: 8612078
  43. Demonstration of an upper limit to the range of association rate constants amenable to study by biosensor technology based on surface plasmon resonance.
    Anal Biochem. 1996 Mar 15;235(2):175-84 PMID: 8833325
  44. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.
    Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12766-71 PMID: 10535997
  45. HTLV-1-induced cell fusion is limited at two distinct steps in the fusion pathway after receptor binding.
    J Cell Sci. 2000 Jan;113 ( Pt 1):37-44 PMID: 10591623
  46. Structure of influenza haemagglutinin at neutral and at fusogenic pH by electron cryo-microscopy.
    FEBS Lett. 1999 Dec 17;463(3):255-9 PMID: 10606732
  47. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
    J Virol. 2000 Jan;74(2):627-43 PMID: 10623724
  48. NMR solution structure of complement-like repeat CR3 from the low density lipoprotein receptor-related protein. Evidence for specific binding to the receptor binding domain of human alpha(2)-macroglobulin.
    J Biol Chem. 2000 Feb 4;275(5):3264-9 PMID: 10652313
  49. Identification of a cellular cofactor required for infection by feline leukemia virus.
    Science. 2000 Mar 10;287(5459):1828-30 PMID: 10710311
  50. Soluble receptor-induced retroviral infection of receptor-deficient cells.
    J Virol. 2000 Jul;74(14):6469-75 PMID: 10864659
  51. Identification of the minimal functional unit in the low density lipoprotein receptor-related protein for binding the receptor-associated protein (RAP). A conserved acidic residue in the complement-type repeats is important for recognition of RAP.
    J Biol Chem. 2000 Jul 14;275(28):21017-24 PMID: 10747921
  52. Energetics of the HIV gp120-CD4 binding reaction.
    Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9026-31 PMID: 10922058
  53. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.
    Annu Rev Biochem. 2000;69:531-69 PMID: 10966468
  54. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.
    J Virol. 2001 Apr;75(8):3685-95 PMID: 11264358
  55. Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion.
    J Virol. 2001 Oct;75(19):9096-105 PMID: 11533173
  56. The stoichiometry of trimeric SIV glycoprotein interaction with CD4 differs from that of anti-envelope antibody Fab fragments.
    J Biol Chem. 2001 Nov 16;276(46):42667-76 PMID: 11544255
  57. The solution structure of the viral binding domain of Tva, the cellular receptor for subgroup A avian leukosis and sarcoma virus.
    FEBS Lett. 2001 Dec 7;509(2):161-8 PMID: 11768384
  58. Lipoprotein receptors: signaling functions in the brain?
    Cell. 1999 Jun 11;97(6):671-4 PMID: 10380917
  59. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Biochemistry. 1999 Jul 20;38(29):9405-16 PMID: 10413516
  60. The mammalian low-density lipoprotein receptor family.
    Annu Rev Nutr. 1999;19:141-72 PMID: 10448520
  61. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
    J Virol. 2004 Dec;78(24):13430-9 PMID: 15564453
  62. Solution structure of the viral receptor domain of Tva and its implications in viral entry.
    J Virol. 2002 Mar;76(6):2848-56 PMID: 11861852
  63. A single glycosylation site within the receptor-binding domain of the avian sarcoma/leukosis virus glycoprotein is critical for receptor binding.
    Virology. 2002 Mar 15;294(2):354-63 PMID: 12009877
  64. Diverse roles for the LDL receptor family.
    Trends Endocrinol Metab. 2002 Mar;13(2):66-74 PMID: 11854021
  65. Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses.
    J Virol. 1996 Nov;70(11):7510-6 PMID: 8892869
  66. Mutational analysis of the oligomer assembly domain in the transmembrane subunit of the Rous sarcoma virus glycoprotein.
    J Virol. 1997 Mar;71(3):2383-9 PMID: 9032375
  67. Role of basic residues in the subgroup-determining region of the subgroup A avian sarcoma and leukosis virus envelope in receptor binding and infection.
    J Virol. 1997 May;71(5):3458-65 PMID: 9094617
  68. Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module.
    Nature. 1997 Aug 14;388(6643):691-3 PMID: 9262405
  69. Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein.
    J Virol. 1997 Dec;71(12):9722-31 PMID: 9371638
  70. Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein.
    J Cell Biol. 1997 Dec 15;139(6):1455-64 PMID: 9396751
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2005-03-00
Pages
3488-99
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC1075726
Subset
IM
Grants
NIAID NIH HHS · R01 AI022470 · United States
NIAID NIH HHS · AI22470 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com